Alacizumab (KDR/VEGFR2/CD309) - Research Grade Biosimilar, Unconjugated, Monoclonal

Artikelnummer: PRS-10-255
Artikelname: Alacizumab (KDR/VEGFR2/CD309) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer: PRS-10-255
Hersteller Artikelnummer: 10-255
Alternativnummer: PRS-10-255-0.1
Hersteller: ProSci
Kategorie: Antikörper
Immunogen: Humanized / KDR/VEGFR2/CD309 [Homo sapiens]
Konjugation: Unconjugated
Alternative Synonym: CDP791,g165 DFM-PEG
Klonalität: Monoclonal
Konzentration: batch dependent
Puffer: PBS buffer pH7.5
Quelle: CHO cells
Application Verdünnung: Optimal dilutions for each application to be determined by the researcher.